Pharma-News Rss Feed


PharmaTimes: News RSS

AZ’s Saphnelo scores US approval for systemic lupus erythematosus (Mo, 02 Aug 2021)
Saphnelo is the first type I interferon receptor agonist to receive regulatory approval
>> mehr lesen

EC approves BMS’ Opdivo as adjuvant treatment for oesophageal or GEJ cancer patients (Mon, 02 Aug 2021)
The approval is based on Phase III results from the CheckMate-577 trial
>> mehr lesen

UCB’s bimekizumab issued NICE recommendation for severe plaque psoriasis (Mon, 02 Aug 2021)
Bimekizumab is the first to follow NICE’s new expedited appraisal process
>> mehr lesen

More than 85 million COVID vaccines administered across the UK, reports DHSC (Mon, 02 Aug 2021)
Over 88% of adults have had a first dose and over 72% both doses
>> mehr lesen

NICE publishes ‘rapid’ guideline on rare blood clots associated with COVID-19 jab (Fri, 30 Jul 2021)
Although condition is extremely rare, it requires ‘swift diagnosis and urgent treatment’ says NICE
>> mehr lesen